Iontronic Tech Promises Hope in Slowing Malignant Brain Tumors by Lilu Anderson 20.06.2024 "Iontronic tech shows promise in slowing malignant brain tumor growth by continuously delivering low-dose drugs, bypassing the blood-brain barrier."
Biotechnology Diversity: Driving Innovation #DiversityinBiotechnology by Lilu Anderson 19.02.2024 Diversity in biotechnology and venture capital is crucial for driving innovation and breakthroughs in healthcare, according to Dr. Stanley Lewis. ...
Revolutionizing Success: Diversity Boosts Biotech VC Funding by Lilu Anderson 19.02.2024 Efforts to diversify biotech venture capital funding could lead to innovation, breakthroughs in healthcare, and improved outcomes for minorities.
Merrimack Pharmaceuticals Closure: Impact on Shareholders by Mark Eisenberg 14.02.2024 Merrimack Pharmaceuticals is set to dissolve after receiving a $225 million payment for FDA approval. Shareholders will receive a dividend ...
G1 Therapeutics Phase 3 Trial Update: Market Response by Mark Eisenberg 13.02.2024 Shares of G1 Therapeutics plunged 46% after disappointing results from their Phase 3 trilaciclib combination trial for triple-negative breast cancer. ...